Filing Flows › Lyell Immunopharma (LYEL) › How it makes money
How Lyell Immunopharma (LYEL) makes money
Lyell Immunopharma (LYEL) made $3K of revenue in the third quarter 2026 (Q3 2026), -80% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $3K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $3K | -80% |
| Q2 2026 | $4K | -50% |
| Q1 2026 | $2K | -71% |
| Q4 2025 | $6K | -46% |
| Q3 2025 | $15K | -56% |
| Q2 2025 | $8K | -38% |
| Q1 2025 | $7K | +133% |
From Lyell Immunopharma's 10-Q filed Nov 4, 2026 (on EDGAR).
Questions
How does Lyell Immunopharma make money?
Lyell Immunopharma (LYEL) made $3K of revenue in the third quarter 2026 (Q3 2026), -80% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.